The human papillomavirus type 16 (HPV-16) E7 gene cooperates with an activated ras oncogene to transform primary rodent cells and is important in the immortalization of cervical keratinocytes. We have generated a series of point mutations within the E7 gene and show that mutation of residues serine 31 and serine 71 affect the phosphorylation of the E7 protein, but do not alter its ability to cooperate with ras. Further mutations which alter cysteine residues in a -Cys-X-X-Cys-motif decrease transformation markedly, although they do not abolish it entirely. All the mutations generated displayed a decreased ability to transactivate the adenovirus E2 promoter. These results show that neither phosphorylation of E7 nor its ability to transactivate are required for transformation by E7.
The human papillomavirus type 16 (HPV-16) E7 gene cooperates with an activated ras oncogene to transform primary rodent cells and is important in the immortalization of cervical keratinocytes. We have generated a series of point mutations within the E7 gene and show that mutation of residues serine 31 and serine 71 affect the phosphorylation of the E7 protein, but do not alter its ability to cooperate with ras. Further mutations which alter cysteine residues in a -Cys-X-X-Cys-motif decrease transformation markedly, although they do not abolish it entirely. All the mutations generated displayed a decreased ability to transactivate the adenovirus E2 promoter. These results show that neither phosphorylation of E7 nor its ability to transactivate are required for transformation by E7.
Human genital papillomaviruses (HPVs) are frequently associated with cervical dysplasias and neoplasias. HPV types 16, 18, 31 and 33 are commonly found in high grade lesions and carcinomas, whereas types 6 and 11 are typically found in condylomata and low grade cervical intraepithelial lesions (Diirst et al., 1983; Gissmann et al., 1983) . In the majority of cervical carcinomas the HPV DNA is integrated into the cellular genome, integration usually occurring within the viral E1 or E2 open reading frames (ORF) and is often accompanied by deletions in this region (Schwarz et al., 1983; SchneiderGadicke & Schwarz, 1986) . The viral early region encoding the E6 and E70RF is selectively retained (Schwarz et al., 1983; Schneider-Gadicke & Schwarz, 1986) and expressed in cervical cancer-derived cell lines (Smotkin & Wettstein, 1986; Androphy et al., 1987; Banks et al., 1987) . Transformation of primary rodent epithelial cells by genital HPVs requires a functional E7 gene to cooperate with the activated ras (Phelps et al., 1988; Storey et al., 1988 Storey et al., , 1990 ) orfos oncogenes (Crook et al., 1988) .
The HPV-16 E7 protein undergoes phosphorylation at serine residues (Smotkin & Wettstein, 1987) and the Nterminal region of the protein shares sequence homology to adenovirus E1A (Phelps et al., 1988) and simian virus 40 (SV40) large T antigen (Vousden & Jat, 1989) (Phelps et al., 1988) . Residues within this region are important for E7 to bind p105, the retinoblastoma gene product (Dyson et al., 1989) . The C-terminal region of the E7 protein contains a pair of-Cys-X-X-Cys-motifs, first identified in the transcription factor TFIIIA (Hanas et al., 1983; Miller et al., 1985) , which probably stabilize this region of the protein and coordinate zinc.
To investigate the role of phosphorylation and the -Cys-X-X-Cys-motif on cell transformation and transactivation a series of serine and cysteine mutants were generated. When transfected into primary cells these mutations showed that E7 probably undergoes phosphorylation at serine 31 and serine 71, of which serine 71 is conserved amongst oncogenic HPV types, and that decreased phosphorylation did not affect cotransformation with ras. However, mutation of core cysteine residues within the -Cys-X-X-Cys-motif greatly reduced, but did not abolish, cotransformation. All the mutants generated showed a decreased ability to transactivate, although cells transformed by the mutants were all capable of generating tumours in immunocompetent animals. These results show that transformation and tumorigenesis by HPV-16 E7 are independent of transactivation and the phosphorylation status of the E7 protein.
Cultures of primary baby rat kidney (BRK) cells were prepared and transfected by the DNA-calcium phosphate coprecipitation method (Wigler et al., 1979) . Samples of DNA-calcium phosphate precipitate (0.8 ml) containing 5 txg of each indicated plasmid were added to 0000-9352 © 1990 SGM 90 mm dishes of sub-confluent primary cells and incubated at 37 °C for 16 h. After glycerol treatment the cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5~o foetal bovine serum (FBS) and 500 gg/ml G418. After 3 to 4 weeks colonies were isolated using cloning rings, or the plates were fixed with formal saline and stained using Giemsa stain. For transient chloramphenicol acetyltransferase (CAT) assays DNA was introduced into NIH 3T3 cells using lipofection. Lipofection reagent and Optimem medium (Gibco) were used in accordance with the manufacturer's instructions.
A 1.9 kb NsiI fragment of HPV-16 DNA containing the E70RF had been cloned into the expression vector pJ4~ as described previously . This fragment was excised using BamHI and cloned into BamHI-cut M13 mpl8 for in vitro mutagenesis. Mutagenesis reactions used an oligonucleotide-directed in vitro mutagenesis system (Amersham) and was used in accordance with the manufacturer's recommendations. Single base mutations were generated using 20-mer or 21-mer oligonucleotides, whereas a double mutant was generated using a 32-mer. DNA sequencing showed that only the required changes had occurred. The E7 mutants were then cloned into pJ4f] and tested for transformation, transactivation and phosphorylation.
For immunoprecipitation 90 mm dishes of the subconfluent transformed cell lines were used. For cysteine labelling the cells were starved for 1 h in DMEM minus cysteine medium containing 5 ~o dialysed FBS and then labelled for 1 h in 3 ml DMEM minus cysteine containing 5~o dialysed FBS and 1 mCi [35S]cysteine. For phosphate labelling the cells were not pre:starved, but incubated directly in 3 ml DMEM containing 10~ phosphate, 5~ FBS and 1 mCi inorganic 32p. After labelling the cells were washed once in phosphatebuffered saline (PBS) and lysed at 4 °C in 250 gl extraction buffer (250 mM-NaC1, 0.1 ~ NP40, 50 mM-HEPES pH 7-0 and 0-1 ~o aprotinin). The lysate was cleared at 13000g for 2 min and the E7 protein precipitated using a rabbit anti-E7 serum (Smotkin & Wettstein, 1986) . Seventy-five gl of 20~ Protein ASepharose was then added and allowed to react for 45 min at 4 °C. The Protein A-Sepharose was then pelleted, washed three times with extraction buffer and the pellet was resuspended in SDS sample buffer and boiled for 5 min. The Protein A-Sepharose was then pelleted and the supernatant removed and analysed by SDS-PAGE and fluorography. For Western blot analysis the HPV-16 E7 protein from the transformed lines was immunoprecipitated from a 90 mm dish as described above, except no radiolabel was used. Proteins separated by SDS-PAGE were transferred to nitrocellulose membranes as described (Banks et al., 1987) . E7 protein was detected using a mouse monoclonal antibody, E7 IV (Oltersdorf et al., 1987) and 125I-labelled anti-mouse immunoglobulins.
CAT assays were performed as previously described (Spalholz et al., 1985) in NIH 3T3 cells. Briefly, the cells were lysed by sonication and the lysate was cleared by centrifugation at 13000 g for 2 min. The protein concentration was estimated using the Bio-Rad protein assay so that each CAT assay contained the equivalent amount of protein. The protein extracts were incubated with 0.5 gM-[14C]chloramphenicol (53 Ci/mmol) and 10 mM-acetyl-CoA in 0.25 M-Tris-HCI pH 7.5. After a 2 h incubation at 37 °C the reaction mixtures were extracted with ethylacetate, dried and the products separated by ascending thin-layer chromatography and localized by autoradiography. Spots of acetylated and unacetylated chloramphenicol were excised and quantified by liquid scintillation: Transfection efficiencies were monitored by including into each transfection expcriment 5 gg of the plasmid pCH110 (Hall et al., 1983) , which contains an Escherichia coli lacZ gene downstream of an SV40 promoter. [3-Galactosidase activity in the cell extracts was determined by the method of Miller (1972) .
Mutations were generated in the E70RF by oligonucleotide-directed in vitro mutagenesis as described earlier and the amino acid changes are shown in Table 1 . The E7 protein undergoes phosphorylation at serine residues (Smotkin & Wettstein, 1987) , so in order to investigate the role of phosphorylation in transformation and transactivation each serine was individually substituted by another amino acid, which was chosen to minimize the disruption of the secondary and tertiary structure of the protein. The carboxy-terminal region of the E7 protein contains pairs of -Cys-X-X-Cys-motifs, which probably stabilize this region of the protein by coordinating zinc. These cysteine residues were either mutated singly or doubly, forming the mutants E7cys91-and E7cys91-/94-, respectively. Mutation of these cysteines in the -Cys-X-X-Cys-core to glycines would presumably abolish the ability of the E7 protein to bind zinc and consequently alter the secondary structure of this part of the protein.
HPV-16 E7 wild-type or mutant gene sequences in pJ4f~ were transfected into sub-confluent cultures of primary BRK cells. All transfections contained pSV2-neo, encoding G418 resistance and the cooperating oncogene was EJ-ras (Shih & Weinberg, 1982) in all cases. Table 2 shows that transfection of E7 sequences mutated at individual serine residues only slightly decreased the ability of E7 to cooperate with ras to transform these cells. However, in separate experiments using E7 constructs mutated at either Cys 91, or a double mutant cys91-/94-, both of which would destroy a -Cys-X-X-Cys motif at the C terminus of the protein, the * Number of G418-resistant colonies formed 3 weeks after transfection of HPV-16 E7 wild-type or mutated sequences into primary cultures of BRK cells. A 90 mm dish of subconfluent BRK cells was transfected with 5 ~tg each of HPV DNA, pEJ6.6 (ras) and pSV2-neo. frequency of colony formation was reduced by about 25-to 50-fold (Table 2) . Colonies were isolated and have been growing as cell lines for more than 6 months and show no sign of senescence. The cells were clearly transformed, since they formed rapidly growing tumours in syngeneic rats 2 to 3 weeks after injection. None of the mutations in the E7 gene completely abolished its ability to cotransform with ras. Omission of either the ras plasmid (pEJ6.6) or pSV2-neo resulted in no colony formation.
The colonies obtained by transfection of B R K cells by either of the E7 cysteine mutants were morphologically very different to those obtained by transfection of the wild-type sequence. The E7 cysteine mutant-transformed cells were always substantially larger and contained many vacuoles in the cytoplasm. Histological staining using oil red O showed that these vacuoles contained lipid (data not shown).
Cells were either labelled with [35S]cysteine or inorganic 32p and immunoprecipitated using a polyclonal rabbit serum raised against a t r p E -H P V -1 6 E7 fusion protein (Smotkin & Wettstein, 1986) (Fig. 1) . 
Immunoprecipitation of [3SS]cysteine-labelled proteins
showed that the E7 mutant-transformed lines contained an E7 protein of the same relative mobility as the wildtype virus-transformed cells (Fig. la) . However, there was no detectable labelling of the E7ser31-or E7ser71-proteins by 32p, suggesting that phosphorylation may normally occur at these residues in the wild-type protein (Fig. l b) , although it cannot be ruled out that any individual mutation may affect the secondary and tertiary structure of the protein in such a manner as would lead to an alteration in the ability of the protein to undergo phosphorylation. Western blot analysis of the transformed cell lines (Fig. l c) (Phelps et al., 1988) . The ability of each of the mutants to transactivate was assayed in N I H 3T3 cells using the plasmid pE2 : : CAT (Murthy et al., 1985) . Each of the E7 serine mutants was able to transactivate the adenovirus E2 promoter, but at reduced levels compared to wild-type E7 (Table 3) , although all of these mutants were transformationcompetent. Transactivation activity of E7 proteins mutated in the -Cys-X-X-Cys-region had reduced (E7cys91-/94-) or no activity (E7cys91-). The tumorigenicity of cell lines was determined in syngeneic, immunocompetent Fischer rats bred under specific pathogen-free conditions at the ICRF and maintained under minimal disease conditions for the duration of the experiments. The preparation of cells for tumorigenicity testing was as described by Crook et al. (1988) . The required number of cells were resuspended in 0.2 ml PBS and injected subcutaneously into either flank of the animal. When 2 x 106 cells transformed by either the wild-type or any of the E7 mutants were injected subcutaneously into the flank of the rat, tumours developed at the site of injection within 2 to 3 weeks. These generally enlarged for 2 weeks before resolving and disappearing. At lower doses of 2 x 104 and 2 × 105 cells all lines except E7ser63-showed similar patterns of tumour development to the wild-type cells. Tumours developed at the site of injection, but were smaller and regressed more quickly than wild-type. The E7ser63-cells did not form tumours at either of the lower doses. The effect of ras on the tumorigenicity of these lines is being investigated further to determine whether the reduced tumorigenic activity can be attributed to either the mutated E7 or ras.
Short communication
This paper describes a series of point mutations in the HPV-16 E7 gene and examines their effect on transformation and transactivation by the E7 protein and also the contribution of the phosphorylation status of the E7 protein towards these activities. The mutations fall into two distinct groups. The first contains those mutations affecting individual serine residues of the E7 protein, which were mutated because E7 is known to undergo serine phosphorylation in CaSki cells (Smotkin & Wettstein, 1987) . The other group involves mutation of cysteine residues at the C terminus of the protein within the -Cys-X-X-Cys-core of a 'zinc finger' motif. The N terminus of the HPV-17 E7 protein shares sequence homology to conserved regions 1 and 2 of sequenced adenovirus types and can transactivate the adenovirus E2 promoter (Phelps et al., 1988) . Conserved region 3 of E 1A has a -Cys-X-X-Cys-motif that is necessary and can be sufficient for transactivation of early promoters (Glenn & Ricciardi, 1985 : LiUie et al., 1986 , although the amino acids within the EIA and E7 loop structures show no sequence homology.
Mutations altering individual serine residues to either alanine or glycine had no significant effect on the cotransforming ability of E7. However, cells transformed by ser31-, ser71-and ser95-all had reduced steady-state levels, suggesting that only a low steadystate level of E7 protein is necessary for transformation. The cys91-mutant could not be detected by either immunoprecipitation or Western blot in several individually isolated transformed clones, suggesting that E7 has a high turnover rate and low steady-state levels. 32p labelling of the serine mutants showed that ser31-and ser71-incorporated less 3zp than the wild-type, suggesting that, at least in this system, E7 may undergo phosphorylation at residues Ser 31 and Ser 71, and since Ser 31 occurs within a potential casein kinase II recognition sequence, E7 may undergo phosphorylation by two independent mechanisms. Serine 71 is conserved amongst oncogenic HPVs such as types 18, 31 and 33, but a cysteine is found at this position in types 6 and 11. However, it cannot be ruled out that any particular mutation may alter the tertiary structure of the protein and so affect phosphorylation at another site.
The tumorigenicity of these lines was assessed in syngeneic animals. All of the E7 serine mutant lines formed rapidly growing tumours comparable with those of the wild-type, indicating that phosphorylation must be only a minor feature of the tumorigenic potential of E7. It seems likely then that phosphorylation does not affect the ability of E7 to cooperate with ras in transforming primary rodent cells, but phosphorylation may have an important role in modulating E7 function and its interaction with other proteins in other cell systems. In contrast to the serine mutations, mutations affecting the cysteine residues near the C-terminus of the molecule within a -Cys-X-X-Cys-motif reduced the cotransforming ability of E7 by about 25-to 50-fold, suggesting that this structure was necessary, but not sufficient, for cotransformation. Similar mutants described by Edmonds & Vousden (1989) also showed a decreased ability to transform NIH 3T3 ceils.
We were also interested in the transactivating capabilities of the mutants. All of the mutants, with the exception of E7cys91-were capable of transactivating the adenovirus E2 promoter, albeit to a lesser extent than the wild-type sequence. This would suggest that transactivation by E7 is not critical for its cotransforming activity. Neither E7 nor E1A seem to bind to DNA directly (Feldman et al., 1982; Ferguson et al., 1985) , but E7 binds to the retinoblastoma gene product, p 105, in the region of E7/E1A homology in the N-terminal part of the molecule (Dyson et al., 1989) . Mutations, such as those described here, that affect the C-terminal part of the E7 molecule, and in particular those which affect residues within the zinc finger structure, will be of interest in further investigations of cellular proteins that bind to and modulate E7 function.
